Background: We performed a study to identify differences in the urinary microbiome associated with chronic allograft dysfunction (CAD) and compared the urinary microbiome of male and female transplant recipients with CAD.
| INTRODUC TI ON
Chronic allograft dysfunction (CAD) is a potential complication in kidney transplant recipients and can herald allograft failure. Modern immunosuppression and antimicrobial prophylaxis has reduced acute allograft losses, but long-term fibrotic changes over the lifespan of the allograft have persisted. 1 Much research has been conducted to elucidate causative factors in the development of CAD. The microbiome of transplant recipients is increasingly studied as a factor associated with CAD. The gut microbiome in allograft recipients has been studied, both to quantify alterations in normal gut flora following immunosuppressive therapies 2, 3 and the effects of microbiome alterations on immune function, although these studies have looked at mouse models 5 or non-transplant human cohorts. 6 Alterations in the normal gut microbiome have been shown to stimulate intestinal innate and adaptive immune mechanisms, pro-inflammatory cytokines, and inflammation. 7 Conversely, absence of regulatory T cells in mice was associated with increased Th2-type inflammation as well as alterations in microbiota, suggesting that chronic inflammation can result in dysbiosis. 8 Thus, the relationship between the microbiome and the transplanted host appears to be bidirectional. 8, 9 One promising area of study is the human urinary microbiome and its relation to kidney allograft function. Once felt to be a sterile body site, there is increasing knowledge of the composition of the urinary microbiome in healthy hosts. [10] [11] [12] [13] Alterations in the urinary microbiome have been explored in a variety of lower urinary tract disorders such as urinary incontinence, interstitial cystitis, urologic cancers, and chronic prostatitis, 10 but little is yet known about urinary microbiome alterations in renal allograft dysfunction.
Quantification of the urinary microbiome in renal allograft recipients has been performed in small cohorts, 14, 15 and dysregulation of the microbiome has been associated with interstitial fibrosis and tubular atrophy (IFTA). 16 However, to our knowledge, the urinary microbiome has not been studied in CAD prior to IFTA development. We hypothesized that CAD is associated with alterations in the urinary microbiome in renal transplant recipients. To test this hypothesis,
we performed a case-control analysis of urine microbiome from kidney allograft recipients with and without CAD using 16S ribosomal RNA (rRNA) V4 microbial sequences for bacteria as well as Internal
Transcribed Spacer rRNA (ITS1 and ITS2 rRNA) region for fungi.
The objective was to compare the urinary microbiome profile in female and male kidney transplant recipients with CAD compared to female controls without CAD. Another objective was to compare the urinary microbiome profile of male kidney transplant recipients with CAD to those of female transplant recipients with CAD. The last objective was to compare urinary microbiome profile in females with CAD and those without CAD.
| MATERIAL S AND ME THODS

| Study design
This is a case-control study nested within existing cohorts. Adult par- Cases were defined as adult male and female subjects at least 1 year post-transplantation returning to clinic with serum creatinine (SCr) persistently 25% above their 3 month post-transplantation baseline. If both the most recent SCr value and the closest previous value at least 1 week apart were 25% above the baseline value, this was considered a persistent rise. Controls were defined as female subjects at least 1 year post-transplantation returning to clinic with SCr persistently the same or better than their 3 month post-transplantation baseline. Similarly, if the most recent SCr and the closest prior value at least 1 week before were the same or better than baseline, it was considered persistently similar to baseline SCr.
The 3 month post-transplantation SCr had already been obtained in our database using three SCr measurements at least 1 week apart.
Exclusion criteria comprised fever ≥100°F in the last 72 hours, recent acute infection with use of antibiotics, or probiotic use at the time of visit for microbiome sample collection. This study was approved by institutional IRB at University of Minnesota, and all subjects gave written informed consent.
| Sample collection
Patients collected clean-catch urine samples in a sterile container during the study visit. These samples were placed on ice and promptly transported to the laboratory, where they were stored in an −80°C freezer until the time of DNA extraction.
| Microbial and fungal DNA extraction
For the isolation of DNA, urine samples were gradually thawed in a laminar airflow hood to avoid cross-contamination. A modified MO BIO protocol including enzymatic lysis [17] [18] [19] and addition of 0.5 mm beads 20 was followed to aid in isolation of fungal DNA. After enzymatic lysis, the samples were transferred to a bead tube containing a mixture of 0.5 mm beads (MO BIO Laboratories: Qiagen
Company, Germantown, MD, USA) and 0.1 mm beads from the Mo Bio Powerlyzer power soil kit (MO BIO Laboratories). The standard manufacturer's protocol was followed for all the subsequent steps. DNA was quantitated using a NanoDrop spectrophotometer (ThermoFisher, Grand Island, NY, USA). Negative extraction controls and mock community cultures and DNA extracts (Zymoresearch, Irvine, CA, USA) were processed in the same fashion.
| 16S and ITS1/ITS2 sequencing and amplification
Those samples that met a qPCR threshold concentration of at least 1000 molecules/µL for 16S V4, ITS1, and ITS2 were processed for amplicon library creation and sequencing at the University of Minnesota Genomics Center. Ribosomal 16S V4 and fungal ITS1
and ITS2 regions were amplified using a dual-index DNA barcoding approach with KAPA Hi-Fidelity HotStart DNA polymerase PCR kit (Kapa Biosystems, Wilmington, MA, USA), and libraries were created using a Nextera XT system (Illumina). 21, 22 Samples were spiked with 15% phiX and sequenced with MiSeq 600 cycle V3 kit (Illumina) to generate 50 000-100 000 reads per sample.
| Sequence analysis
The resulting 16SrRNA raw sequence information was converted to fastq files (Illumina) and processed for quality. Adaptors were removed, and remaining sequences were filtered using a threshold of Q37, and sequences below 33 base pairs were removed, and paired ends were merged using the computational tool FLASH. 
| Statistical analysis
For each individual OTU, we applied the Wilcoxon rank-sum test to compare differences between case and control groups. In addition,
we also evaluated the aggregated OTU distribution difference at the genus level between the two groups using the kernel RV coefficient (KRV) test. 30, 31 To correct for multiple testing, we controlled the false discovery rate (FDR) at the 0.05 level identify significant tests. Kruskal-Wallis nonparametric ANOVA using QIIME was also performed on taxonomic counts data to identify unique statistically significant OTUs, which corroborated with kernel RV tests.
Furthermore, linear discriminant analysis effect size (LEfSe) was also employed to identify differentially abundant OTUs specific to the cohorts (case/control) for determining the biomarkers. In this analysis, LEfSe software determines biomarkers by relative abundance, emphasizing both statistical significance as well as biological consistency and effect relevance. 
| RE SULTS
The characteristics of the study participants are outlined in Table 1 .
Several subjects in the case and control cohorts underwent allograft biopsies for elevations in SCr above 3-month baseline or for suspected acute rejection (AR) episodes prior to urinary microbiome sample collection. For some subjects, this was the first allograft biopsy obtained for persistent elevation in SCr ≥25% above 3-month post-transplantation baseline and is hereafter referred to as the index biopsy. These results are summarized in 
| Urinary microbial diversity in cases and controls
Each urine sample contained a median of 23 566 ± 9,320 bacte- S3 ). Therefore, further analysis was restricted to bacterial microbiome due to this low yield. The overall bacterial taxonomic compositions at phyla level for these samples are shown in Figure S1 .
Bacterial sample diversity was measured in two ways. All the samples were rarefied to 1000 sequences per sample be- Figure S4B ). We also measured beta diversity, or differences between differing communities, by weighted and unweighted UniFrac ANalysis Of SIMilarity (ANOSIM) calculations in QIIME ( Figure S5 ). There was no statistically significant difference in beta diversity by weighted and unweighted UniFrac (ANOSIM; P = 0.09 and P = 0.07, respectively).
| Analysis of cases vs controls
No individual OTU showed any significant association with CAD when comparing cases and controls. However, when all OTUs were aggregated and analyzed with KRV testing, 30, 31 there was a statistically significant difference in OTUs between cases and controls (P = 0.016).
TA B L E 1 Baseline characteristics of the study participants. By study design, the control cohort included only female participants At the genus level, 378 distinct genera were identified but only 79 existed in >10% of samples. Using KRV, when controlling for false discovery rate (FDR) at 0.05, we identified one significant genus, Corynebacterium, preferentially associated with cases of CAD versus controls (P = 0.0005; Figure S6 ). Of the selected OTUs, 21 were found to be in statistically significant higher abundance in cases vs controls (P = 0.01) using Kruskal-Wallis one-way ANOVA testing (Table 5) .
Among them is the genus Corynebacterium which was found to be in corroboration with the KRV testing (P = 0.0008). This is also evident from the heat map constructed with the relative abundance of the most significant taxa across all the samples ( Figure S7 ).
Linear discriminant analysis effect size analysis identified 22 discriminant features or distinct OTUs within the cohorts. Using a linear discriminant analysis (LDA) score threshold of >2.0, ten OTUs within the control set and twelve OTUs within the cases were identified (Figures 1 and 2 ). With this analytic framework, significant taxonomic groupings that emerged were the class Actinobacteria (includes the genus Corynebacterium), order Bacillales (includes the genus Staphylococcus), and genus Corynebacterium within cases, as well as the class Cytophagia which were more prevalent in controls.
| Subset analysis of female cases vs female controls
An analysis using KRV, comparing female cases versus female controls found a similar trend toward significance (P = 0.13) but was underpowered. The Kruskal-Wallis testing between female cases versus female controls also identified the genus Corynebacterium with P-value 0.01 similar to all cases vs controls analysis (Table 6) .
Linear discriminant analysis effect size analysis performed between female cases versus female controls showed that the same taxonomic groupings as all cases vs controls analysis emerged, such as class Actinobacteria, genus Staphylococcus for cases, and class
Cytophagia for controls which were significantly different ( Figure 3 ).
| Analysis of cases based on sex
Because the initial study was designed as a sex supplement to the existing cohorts to analyze sex differences in post-transplantation outcomes, the control cohort was restricted to female participants. Once it was determined that there were significant differences between the cases and controls, we analyzed male versus (Monte Carlo permuted two sample t test; P = 0.183; Figure S8 ).
Despite a higher mean Shannon index for male cases, the calculated equitability (a measure of homogeneity within the sample) was higher in males (82.5%) compared with females (95%), reflecting a more homogenous male urinary microbiome compared to female cases. Weighted and unweighted UniFrac revealed significant grouping comparing male vs female cases (ANOSIM; P = 0.007; Figure S5 ).
When KRV testing was performed between female and male cases, there was a significant difference between female cases and male cases (P-value <0.01). When FDR was controlled at 0.05 level, the microbiome class Bacilli (P = 8.00 × 10 −4 ) and the order Lactobacillales (P = 0.0027) were found to be significantly associated with female cases.
Linear discriminant analysis effect size analysis of the male versus female cases of CAD was also performed using LDA threshold >3.0 (Figure 4 ). Higher LDA scores correlate with more "separate" or distinct groupings or unique microbial signatures. Among male cases, the predominant phylum found was the Gram-nega- (Figure 5 ).
| Additional subset analyses based on tacrolimus level and ancestry
We performed subset analyses based on immunosuppression and dosing, which have been correlated with post-transplantation changes in gut microbiota 3 and with allograft outcomes. 33, 34 Of 67
patients, a total of 31 patients were on tacrolimus while the remainders were on cyclosporine (two patients were not on any calcineurin inhibitor). We grouped these patients into high (≥1.4) and low (<1.4)
tacrolimus groups based on their dose-normalized levels. There were no significant differences in Shannon diversity or beta diversity indices observed between these groups. However, by LEfSe, class
Clostridia emerged as a significant taxon abundant in the low dosenormalized tacrolimus group. With Kruskal-Wallis one-way ANOVA testing, genera Actinomyces (P = 0.008) and Anaerococcus (P = 0.02)
were identified as more abundant in low tacrolimus dose-normalized level group ( Figure S9 ).
Similar analyses were performed on all of the urinary microbiome samples based on patient ancestral origin (Caucasian vs nonCaucasian), as expression of cytochrome P450 (CYP) enzymes are linked to drug metabolism and intestinal absorption of tacrolimus 35 and can be differentially expressed based on ancestry. 36, 37 Only TA B L E 3 The distribution of pathology scores based on Banff criteria for antibody-mediated rejection for the first (if more than one per patient available) kidney allograft biopsies obtained prior to urinary microbiome sample collection described in ) and genera Actinomyces (P = 0.0002) and Megasphaera (P = 0.0002; Figure S10 ). 
TA B L E 5 Statistically significant OTUs by taxonomy using Kruskal-Wallis testing comparing cases (all patients with CAD) versus controls (all patients without CAD
F I G U R E 2 Cladogram of LEfSe Analysis Results comparing cases (all patients with CAD) versus controls (all patients without CAD).
A cladogram organizes individual data points or species by biological hierarchy. In this set, the circular rings represent levels of taxonomy; the outer ring is the Genus level, the ring within this is Family, then Order, then Class, with the innermost intact ring representing Phylum. Linear spokes are used to connect phylogenetic relationships tracing back to higher levels in grouping. For instance, highlighted in red are numerous significant OTUs at the outermost genus level that can all be traced back to a unified class-level association within Actinobacteria. Similarly, there are significant groupings under the larger umbrella of both order Bacillales and class Cytophagia. Taxonomy nomenclature: p = phylum, c = class, o = order, f = family, g = genus, s = species. All denoted OTUs are within kingdom Bacteria
| D ISCUSS I ON
We discovered that the urinary microbiome contains microbiologic signatures specific to patients with CAD Corynebacterium was the only genus found in greater abundance in cases when compared to controls, but there were a number of OTUs that showed a trend toward different abundance in cases versus controls. Using Taxonomy nomenclature: p = phylum, c = class, o = order, f = family, g = genus, s = species. All denoted OTUs are within kingdom Bacteria. The narrow taxonomic rank in each significant OTU is in bolded text.
TA B L E 6 Statistically significant OTUs by taxonomy using Kruskal-Wallis testing comparing cases (female patients with CAD) versus controls (female patients without CAD) genus in the microbiome of cases. The same analyses using only female patients also showed Corynebacterium emerging as a significant genus in cases proving that despite the sex differences, this genus has an association with CAD. While we were unable to identify
Corynebacterium to the species level based on our alignment, there
are Corynebacterium species that are found in the urine in addition to the skin (including C urealyticum) that have been associated with indwelling catheters and can be pathogenic in humans. opsy data, the prevalence of moderate to severe IFTA in our cohort was less than in Salomon's cohort (see Table 3 ); greater than Although numbers are small, our subanalysis based on dose-normalized tacrolimus level and by ancestry highlighted differences in urinary microbial expression, neither of which has been previously studied. Both optimizing choice of calcineurin inhibitor 33 and therapeutic serum drug level have been associated with decreasing rates of acute rejection. 34 With respect to ancestry, race/ethnicity impacts CYP enzymatic expression, tacrolimus dose requirements, 37 and rates of acute rejection that disproportionately affect African-Americans. 39, 40 Rates of kidney allograft survival in AfricanAmerican recipients are lower than in their Caucasian counterparts by more than 5% at 5 years (OPTN data, 2008 (OPTN data, -2015 . Further investigation is needed to determine if the differences highlighted in our findings are attributable more to disparities in dose-normalized tacrolimus level based on ancestry or from differing microbiota between racial groups.
Using only female participants as controls has certain advantages. Original studies quantifying the normal human urinary microbiome have found that the female urinary tract contains both more bacteria and a more heterogeneous population than their male counterparts, owing to anatomic and hormonal differences. Corynebacterium species are known skin and mucosal commensals, and others are known to cause urinary tract infections, but the significant incidence increase in cases suggests their presence is due to more than simple contamination. All patients were instructed by study coordinators on proper clean-catch technique for urine sampling, and this would have minimized skin flora contamination as in other urine microbiome studies with similar outlined protocols. 16 Our study initially set out to identify both bacterial and fungal signatures in the cohort. However, the fungal results were not revealing, due in part to low numbers of OTUs aligning with existing mycobiome libraries, but further study with ongoing development of a more robust ITS1/2 database may shine light onto this 
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